Trademark Overview
On Wednesday, May 4, 2005, a trademark application was filed for DIRECT TO GOVERNMENT MARKETING with the United States Patent and Trademark Office. The USPTO has given the DIRECT TO GOVERNMENT MARKETING trademark a serial number of 78623280. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, July 7, 2006. This trademark is owned by National Foundation of Science Biotechnology and Medical Research. The DIRECT TO GOVERNMENT MARKETING trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Paper & Printed Material Products, Advertising, Business and Retail Services, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:
Electronic media, namely videos, DVDs, CDs and other prerecorded media in the field of healthcare policy, economics, politics, access to and delivery of healthcare and pharmaceuticals, marketing, advertising, public relations, and issues which affect research, development, drug design, quality control, new drug approval, prescription practices, formulary design, pricing and reimbursement in pharmaceutical, biotechnology, medical device, medical insurance, hospital and pharmacy benefit industries
Publications, namely books, magazines, brochures, newsletters in the field of healthcare policy, economics, politics, access to and delivery of healthcare and pharmaceuticals, marketing, advertising, public relations, and issues which affect research, development, drug design, quality control, new drug approval, prescription practices, formulary design, pricing and reimbursement in pharmaceutical, biotechnology, medical device, medical insurance, hospital and pharmacy benefit industries
Consulting services in the field of healthcare policy, economics, politics, access to and delivery of healthcare and pharmaceuticals, marketing, advertising, public relations, and issues which affect research, development, drug design, quality control, new drug approval, prescription practices, formulary design, pricing and reimbursement ; promoting public awareness of the need for improving healthcare through the development of public and private-sector policy initiatives for improving the nature, quality, access to and delivery of healthcare; providing information and informational resources regarding the healthcare policy, economics, politics, access to and delivery of healthcare and pharmaceuticals, marketing, advertising, public relations, and issues which affect research, development, drug design, quality control, new drug approval, marketing, advertising, prescription practices, formulary design, pricing and reimbursement in pharmaceutical, biotechnology, medical device, medical...
Educational services, namely conducting conferences, meetings and seminars in the fields of healthcare, the healthcare industry and healthcare policy and distribution of course materials in connection therewith; educational and advocacy services, including providing policy and strategy recommendations in the field of healthcare in collegiate and graduate institutions; providing online educational information and resources in the fields of the healthcare policy, economics, politics, access to and delivery of healthcare and pharmaceuticals, marketing, advertising, public relations, and issues which affect research, development, drug design, quality control, new drug approval, marketing, advertising, prescription practices, formulary design, pricing and reimbursement in pharmaceutical, biotechnology, medical device, medical insurance, hospital and pharmacy benefit industries
Conducting research in the field of healthcare regarding the healthcare policy, economics, politics, access to and delivery of healthcare and pharmaceuticals, marketing, advertising, public relations, and issues which affect research, development, drug design, quality control, new drug approval, marketing, advertising, prescription practices, formulary design, pricing and reimbursement in pharmaceutical, biotechnology, medical device, medical insurance, hospital and pharmacy benefit industries